Thomas M. Patton

Mr. Thomas M. Patton is a seasoned healthcare executive and board member with operational, strategic, financial, legal, compliance and transactional experience, from start-ups to growth companies, both public and private. He last served as President and Chief Executive Officer of CAS Medical Systems (CASM), a publicly traded developer and distributor of patient monitoring equipment, from 2010 until its sale to Edwards Lifesciences in 2019.

His prior experience includes as Co-Founder, President and CEO of QDX, Inc., a developer of unique micro-fluidic diagnostic technology utilizing digital imaging techniques for hematologic analysis (sold to Abbott Laboratories), as President and Chief Operating Officer of Novametrix Medical Systems, Inc. (NMTX) (sold to Respironics), and CEO of Wright Medical Technology, Inc. Mr. Patton has served on eleven separate Boards of Directors for both public and private medical products and services companies, and currently serves on the Board of Misonix, Inc. (MSON), an ultrasonic surgical tools and wound care company.